Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Rationale: Idiopathic pulmonary fibrosis (IPF) is a devastating disease. Antiinflammatory therapies, including corticosteroids, are of no benefit. The role of monocytes and macrophages is therefore controversial. Objectives: To define the role of monocytes and macrophages during lung fibrogenesis and resolution, and explore the phenotype of the cells involved. Methods: We used multiple in vivo depletional strategies, backed up by adoptive transfer techniques. Further studies were performed on samples from patients with IPF. Measurements and Main Results: Depletion of lung macrophages during fibrogenesis reduced pulmonary fibrosis as measured by lung collagen (P = 0.0079); fibrosis score (P = 0.0051); and quantitative polymerase chain reaction for surrogate markers of fibrosis Col1 (P = 0.0083) and α-smooth muscle actin (P = 0.0349). There was an associated reduction in markers of the profibrotic alternative macrophage activation phenotype, Ym1 (P = 0.0179), and Arginase1. The alternative macrophage marker CD163 was expressed on lung macrophages from patients with IPF. Depletion of Ly6Chi circulating monocytes reduced pulmonary fibrosis (P = 0.0052) and the number of Ym1-positive alternatively activated lung macrophages (P = 0.0310). Their adoptive transfer during fibrogenesis exacerbated fibrosis (P = 0.0304); however, adoptively transferred CD45.1 Ly6Chi cells were not found in the lungs of recipient CD45.2 mice. Conclusions: We demonstrate the importance of circulating monocytes and lung macrophages during pulmonary fibrosis, and emphasize the importance of the alternatively activated macrophage phenotype. We show that Ly6Chi monocytes facilitate the progression of pulmonary fibrosis, but are not obviously engrafted into lungs thereafter. Finally, we provide empirical data to suggest that macrophages may have a resolution-promoting role during the reversible phase of bleomycin-induced pulmonary fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [20]
In the citing paper
“it remains largely unclear what regulates their pro-fibrotic potency in the lung2,3,19–27”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [20]
In the citing paper
“Although it has long been recognized that macrophages play a crucial role in the pathogenesis of lung fibrosis”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [20]
In the citing paper
“removal (27, 28) or repolarizing (27) of interstitial macrophages is both preventative and therapeutic in several mouse models of IPF”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [28]
In the citing paper
“The importance of macrophages in regulating fibrosis is demonstrated by the observation that in mice, deletion of lung macrophages using liposomal chlodronate reduces bleomycin induced lung fibrosis, and a similar effect is obtained if circulating monocytes are depleted using liposomal chlodronate (169).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [169]
Citations
Cites
Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786 · cited 1×
“A new hypothesis was developed in which aberrant wound healing was believed to be the more likely mechanism for disease development (9).”
BackgroundBlood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,655 · cited 1×
“Some authors suggest that in tissue, Ym1-positive macrophages are derived from Ly6C monocytes (49).”
BackgroundSelective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 2×
“This novel finding is in keeping with the role of macrophages during the resolution of liver fibrosis (16) and fits nicely with work showing that alveolar macrophages are involved in the removal of accumulated collagen (29), suggesting that macrophage manipulation for modulation of fibrosis may be possible.”
BackgroundResultSelf-citationCD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 1×
“The archetypal fibrotic lung disease, idiopathic pulmonary fibrosis (IPF), is a devastating disorder with an unknown natural history (1); there are no effective therapies (2), its incidence is rising (3), and it has a median survival of between 2.”
BackgroundCD4 + CD25 + Foxp3 + regulatory T cells induce alternative activation of human monocytes/macrophages
Tiemessen, M. M., Jagger, A. L., Evans, H. G., van Herwijnen, M. J. C., John, S., & Taams, L. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706832104 · Cited by 852 · cited 1×
“CD163, a human marker of alternative macrophage activation (31), was not expressed on lung macrophages from elderly healthy volunteers (Figure 4H), but importantly and in contrast, was shown to be expressed on greater than 90% of lung macrophages from patients with IPF (Figure 4I).”
BackgroundMurine models of pulmonary fibrosis
Moore, B. B., & Hogaboam, C. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2007 · Cited by 796 · cited 1×
“Fibrosis begins to develop after 14 days and usually peaks after 21–28 days (22).”
BackgroundBroekelmann, T. J., Limper, A. H., Colby, T. V., & McDonald, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6642 · Cited by 794 · cited 1×
“Interestingly, a study of patients with IPF using in situ hybridization demonstrated that TGFb1 mRNA was present in macrophages adjacent to fibroblastic foci, but that the foci themselves showed no signal for TGFb1 mRNA (51).”
BackgroundComparison of gene expression profiles between human and mouse monocyte subsets
Ingersoll, M. A., Spanbroek, R., Lottaz, C., Gautier, E. L., Frankenberger, M., Hoffmann, R., Lang, R., Haniffa, M., Collin, M., Tacke, F., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235028 · Cited by 729
Determination of arginase activity in macrophages: a micromethod
Corraliza, I. M., Campo, M. L., Soler, G., & Modolell, M. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90027-2 · Cited by 540 · cited 1×
“Arginase activity (per milligram of protein) in lung homogenates was assessed by the production of urea generated by the arginasedependent hydrolysis of L-arginine as previously described (21).”
MethodUnravelling mononuclear phagocyte heterogeneity
Geissmann, F., Gordon, S., Hume, D. A., Mowat, A. M., & Randolph, G. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2784 · Cited by 529 · cited 3×
“It is important to state that some experts believe that dendritic cells are a subgroup of macrophages (37, 38).”
BackgroundMigratory fate and differentiation of blood monocyte subsets
Tacke, F., & Randolph, G. J. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.025 · Cited by 528 · cited 2×
“Circulating monocytes are CD11b1, CD1151 (32).”
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Moeller, A., Gilpin, S. E., Ask, K., Cox, G., Cook, D., Gauldie, J., Margetts, P. J., Farkas, L., Dobranowski, J., Boylan, C., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1534oc · Cited by 513 · cited 1×
“With this in mind it is tempting to speculate that Ly6C monocytes may be the precursors of lung alternatively activated macrophages, particularly because it has recently been suggested that Ly6C monocytes may be the precursors of circulating fibrocytes (47), which have been shown to be important in pulmonary fibrosis…”
BackgroundSelf-citationKhalil, N., Bereznay, O., Sporn, M., & Greenberg, A. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.727 · Cited by 505 · cited 2×
“Importantly, it has been demonstrated in rodents using the bleomycin model that lung macrophages could be the predominant source of transforming growth factor-b (TGF-b) (12), a most prominent fibrosis-inducing molecule.”
BackgroundMacrophages as APC and the Dendritic Cell Myth
Hume, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5829 · Cited by 501 · cited 3×
“It is important to state that some experts believe that dendritic cells are a subgroup of macrophages (37, 38).”
BackgroundA Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497 · cited 2×
“It has been demonstrated that culture supernatants of alveolar macrophages from patients with IPF increased collagen production by normal lung fibroblasts partly mediated via CCL18, a marker of alternative macrophage activation (10).”
BackgroundDifferential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages
Raes, G., De Baetselier, P., Noël, W., Beschin, A., Brombacher, F., & Hassanzadeh Gh., G. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.597 · Cited by 443 · cited 2×
“Ym1, also called chitinase 3–like protein 3, is an archetypal murine marker of alternatively activated macrophages (30).”
BackgroundThepen, T., Van Rooijen, N., & Kraal, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.499 · Cited by 422 · cited 3×
“Administration of liposomal clodronate is a well-established method of selectively and effectively depleting macrophages (24) including lung macrophages (20).”
BackgroundMethodInfluentialAlternative activation of macrophages: immune function and cellular biology
Varin, A., & Gordon, S. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.009 · Cited by 361 · cited 1×
“Alternatively activated macrophages are associated with fibrogenic phenotypes in mice and humans (15).”
BackgroundRennard, S. I., Hunninghake, G. W., Bitterman, P. B., & Crystal, R. G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7147 · Cited by 340
Gratchev, A., Guillot, P., Hakiy, N., Politz, O., Orfanos, C. E., Schledzewski, K., & Goerdt, S. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00885.x · Cited by 300 · cited 1×
“Crucially, corticosteroids have been shown to induce the alternatively activated, profibrotic macrophage phenotype (17).”
BackgroundTransforming Growth Factor β: A Central Modulator of Pulmonary and Airway Inflammation and Fibrosis
Sheppard, D. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-008aw · Cited by 298 · cited 2×
“TGF-b is widely recognized to be a “master” molecule during the development of lung fibrosis (35) and the fact that lung macrophage modulation limits induced lung fibrosis emphasizes their importance.”
BackgroundLung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages
Landsman, L., & Jung, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3488 · Cited by 258 · cited 6×
“Administration of DT depletes interstitial macrophages and dendritic cells for up to 9 days, and alveolar macrophages and dendritic cells for 2–4 days (26).”
BackgroundInfluentialSerum YKL-40 is increased in patients with hepatic fibrosis
Johansen, J. S., Christoffersen, P., Møller, S., Price, P. A., Henriksen, J. H., Garbarsch, C., & Bendtsen, F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80095-1 · Cited by 252 · cited 2×
“liver fibrosis (42), and it has recently been proposed that it has a role in tissue remodeling and fibrosis (43).”
BackgroundCryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival
Turner-Warwick, M., Burrows, B., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.8.593 · Cited by 244 · cited 1×
“Early studies suggested their importance (4– 6), but the lack of benefit of corticosteroids in treating IPF (7) prompted a rethink.”
BackgroundVermaelen, K., & Pauwels, R. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20064 · Cited by 243
Atabai, K., Jame, S., Azhar, N., Kuo, A., Lam, M., McKleroy, W., DeHart, G., Rahman, S., Xia, D. D., Melton, A. C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40053 · Cited by 237 · cited 1×
“This novel finding is in keeping with the role of macrophages during the resolution of liver fibrosis (16) and fits nicely with work showing that alveolar macrophages are involved in the removal of accumulated collagen (29), suggesting that macrophage manipulation for modulation of fibrosis may be possible.”
ResultCD4+T cells control the differentiation of Gr1+monocytes into fibrocytes
Niedermeier, M., Reich, B., Gomez, M. R., Denzel, A., Schmidbauer, K., Göbel, N., Talke, Y., Schweda, F., & Mack, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906070106 · Cited by 231
Walters, D. M., Cho, H.-Y., & Kleeberger, S. R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1901 · Cited by 206 · cited 1×
“Recent work, however, has suggested that it is a marker of oxidative stress, known to be important in the pathogenesis of lung fibrosis (41).”
BackgroundBaran, C. P., Opalek, J. M., McMaken, S., Newland, C. A., O'Brien, J. M., Hunter, M. G., Bringardner, B. D., Monick, M. M., Brigstock, D. R., Stromberg, P. C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1279oc · Cited by 196
Murray, L. A., Rosada, R., Moreira, A. P., Joshi, A., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Mathai, S., Gulati, M., Herzog, E. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009683 · Cited by 192 · cited 1×
“This fits with recent work showing that CD163(1) monocytes are increased in the circulation of patients with progressive IPF compared with normal control subjects (45).”
BackgroundKhalil, N., Whitman, C., Zuo, L., Danielpour, D., & Greenberg, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116771 · Cited by 186 · cited 1×
“shown in a model of lung fibrosis that corticosteroid treatment has no effect on alveolar macrophage secretion of TGF-b, and that when alveolar macrophages from bleomycin-treated animals are cultured in the presence of corticosteroids there is in fact increased secretion of TGF-b (13).”
BackgroundKolpen, M., Hansen, C. R., Bjarnsholt, T., Moser, C., Christensen, L. D., van Gennip, M., Ciofu, O., Mandsberg, L., Kharazmi, A., Doring, G., et al. (2010) · Thorax · doi:10.1136/thx.2009.114512 · Cited by 184
Nagaoka, I., Trapnell, B. C., & Crystal, R. G. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114669 · Cited by 181
Hochweller, K., Striegler, J., Hämmerling, G. J., & Garbi, N. (2008) · European Journal of Immunology · doi:10.1002/eji.200838659 · Cited by 179 · cited 2×
“For categorical confirmation, we assessed the effect of depletion of lung macrophages on the degree of lung fibrosis using the bleomycin model but using an independent and specific conditional system, that of the CD11c-DTR transgenic mouse (25), and importantly we demonstrate that depletion of lung macrophages results…”
BackgroundMethodCurrent Perspectives on the Treatment of Idiopathic Pulmonary Fibrosis
Walter, N., Collard, H. R., & King, T. E. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200602-016tk · Cited by 174 · cited 1×
“The archetypal fibrotic lung disease, idiopathic pulmonary fibrosis (IPF), is a devastating disorder with an unknown natural history (1); there are no effective therapies (2), its incidence is rising (3), and it has a median survival of between 2.”
BackgroundFuruhashi, K., Suda, T., Nakamura, Y., Inui, N., Hashimoto, D., Miwa, S., Hayakawa, H., Kusagaya, H., Nakano, Y., Nakamura, H., et al. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.02.026 · Cited by 128 · cited 1×
“Furthermore, serum and BAL fluid levels of YKL-40 have recently been found to be elevated in patients with IPF versus normal control subjects (44).”
BackgroundInflammatory Mechanisms Are a Minor Component of the Pathogenesis of Idiopathic Pulmonary Fibrosis
Gauldie, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2202054 · Cited by 127
Self-citationWestcott, D. J., DelProposto, J. B., Geletka, L. M., Wang, T., Singer, K., Saltiel, A. R., & Lumeng, C. N. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091333 · Cited by 115
Wynes, M. W., Frankel, S. K., & Riches, D. W. H. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0504288 · Cited by 105 · cited 1×
“Secretion of insulin-like growth factor-1 by alternatively activated macrophages protects myofibroblasts from apoptosis (50).”
BackgroundKirby, A. C., Raynes, J. G., & Kaye, P. M. (2005) · The Journal of Infectious Diseases · doi:10.1086/498874 · Cited by 97 · cited 8×
“The cell surface markers CD11c, CD11b, and MHC II have been used in varying combinations to define lung macrophages and dendritic cells (26, 36–39).”
BackgroundInfluentialA Role for Dendritic Cells in Bleomycin-induced Pulmonary Fibrosis in Mice?
Bantsimba-Malanda, C., Marchal-Sommé, J., Goven, D., Freynet, O., Michel, L., Crestani, B., & Soler, P. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1164oc · Cited by 86 · cited 1×
“It is likely that by using the CD11c-DTR mouse there is an inherent depletion of lung dendritic cells, and their potential importance in the pathogenesis of pulmonary fibrosis has previously been highlighted (36).”
BackgroundRole of breast regression protein-39/YKL-40 in asthma and allergic responses
Lee, C. G., & Elias, J. A. (2009) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2010.2.1.20 · Cited by 86 · cited 1×
“liver fibrosis (42), and it has recently been proposed that it has a role in tissue remodeling and fibrosis (43).”
BackgroundAlveolar Macrophage Dysregulation in Hermansky-Pudlak Syndrome Type 1
Rouhani, F. N., Brantly, M. L., Markello, T. C., Helip-Wooley, A., O'Brien, K., Hess, R., Huizing, M., Gahl, W. A., & Gochuico, B. R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0023oc · Cited by 72 · cited 1×
“Moreover, a recent study in patients who develop an accelerated form of fibrotic lung disease demonstrated that they have dysregulated alveolar macrophages (14).”
BackgroundPotential role of apoptotic macrophages in pulmonary inflammation and fibrosis
Wang, L., Antonini, J. M., Rojanasakul, Y., Castranova, V., Scabilloni, J. F., & Mercer, R. R. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10220 · Cited by 64 · cited 1×
“It has previously been shown that the effect (of liposomal clodronate) is not caused by apoptosis per se because rats given apoptotic macrophages (27) or apoptotic cells (28) actually develop lung fibrosis.”
BackgroundWang, L., Scabilloni, J. F., Antonini, J. M., Rojanasakul, Y., Castranova, V., & Mercer, R. R. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00245.2005 · Cited by 54 · cited 1×
“It has previously been shown that the effect (of liposomal clodronate) is not caused by apoptosis per se because rats given apoptotic macrophages (27) or apoptotic cells (28) actually develop lung fibrosis.”
BackgroundLacronique, J., Rennard, S. I., Bitterman, P. B., Ozaki, T., & Crystal, R. G. (1984) · PubMed · doi:10.1164/arrd.1984.130.3.450 · Cited by 39
Warshamana, G. S., Pociask, D. A., Fisher, K. J., Liu, J., Sime, P. J., & Brody, A. R. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00229.x · Cited by 38 · cited 1×
“Administration of AdTGF-b by the intratracheal route has been shown to induce prominent lung fibrosis with a peak at 14 days (23).”
Background
Research works printed but not linked: 2
- Gibbons, 2009, A critical role for alternatively activated monocytes and macrophages in the pathogenesis of pulmonary fibrosis [abstract], Thorax, 64, A37
- Gibbons, 2010, Ly6Chi circulating monocytes direct alternatively activated, pro-fibrotic, lung macrophage regulation of pulmonary fibrosis, Thorax, 65, A57
Cited by
Aran, D., Looney, A. P., Liu, L., Wu, E., Fong, V., Hsu, A., Chak, S., Naikawadi, R. P., Wolters, P. J., Abate, A. R., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0276-y · Cited by 4,984
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Alveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377
Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
Self-citationMonocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162152 · Cited by 1,133
“, using Ccr2−/− mice or via the systemic administration of liposomal clodronate) ameliorates fibrosis severity in the lung and other organs (Moore et al., 2001; Gibbons et al., 2011; Wynn and Vannella, 2016).”
BackgroundMethodResult
Metadata
- Authors
- Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A. T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., Hirani, N., Gauldie, J., Iredale, J. P., Sethi, T., & Forbes, S. J.
- Affiliations
- Royal Devon & Exeter NHS Foundation Trust (GB)
- Centre for Inflammation Research (GB)
- Institute of Immunology and Infection Research, and
- Department of Molecular Cell Biology, Vrije University, Amsterdam, The Netherlands
- Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, United Kingdom
- McMaster University (CA)
- King's College London (GB)
- MRC Centre for Regenerative Medicine (GB)
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09-01
- Volume
- 184
- Issue
- 5
- Pages
- 569-581
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2111920665
- Cited by
- 466
- References
- 50
- Citations by year
- 2026: 23 · 2025: 36 · 2024: 32 · 2023: 34 · 2022: 38 · 2021: 38 · 2020: 30 · 2019: 37 · 2018: 31 · 2017: 34 · 2016: 38 · 2015: 23 · 2014: 24 · 2013: 30 · 2012: 15
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, pulmonary fibrosis, Ly6Chi monocytes, M2 macrophages, M2 macrophage polarization, Ym1, arginase-1, CD163, macrophage depletion, adoptive transfer, bleomycin-induced lung fibrosis, fibrosis resolution, collagen deposition
- MeSH terms
- Animals, Bleomycin, Disease Models, Animal, Female, Humans, Immunity, Cellular, Macrophage Activation, Monocytes, Phenotype, Pulmonary Fibrosis, Macrophages, Alveolar, Disease Progression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.